Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 10,000 shares at $6.54 ($65K) on 2017-03-31, disclosed to the SEC on 2017-04-03.
Open-market purchase of $65k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.48 | 7,654 | $50K | 76.4% |
| 2 | $6.54 | 2,346 | $15K | 23.6% |
| Total | $6.49 avg | 10,000 | $65K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |